Prof. Ingo Roeder, Ph.D.
© P.Benjamin/NCTDD
Chair for Medical Biometry and Statistics
NameMr Prof. Dr. rer. med. Ingo Röder
Institute Director
Send encrypted email via the SecureMail portal (for TUD external users only).
Prof. Ingo Roeder is Head of the Institute for Medical Informatics and Biometry. He is a member of the Carl Gustav Carus Medical Faculty at the Technische Universität Dresden. In particular, he holds the Chair for Medical Statistics and Biometry. Since 2015 Prof. Roeder has been scientific head of the Core Unit for Data Management and Analytics (DMA) at the National Centre for Tumor Diseases (NCT) at the partner site Dresden. Between 2014 and 2018 he acted as CIO of the TU Dresden School of Medicine. Since 2018 he ihas been dean of studies at the Faculty of Medicine.
Prof. Roeder’s research focus covers the following areas:
Theoretical Biology/System medicine:
- Application of mathematical models in the context of treatment optimisation/model-based experimental/study design (e.g. regarding CML, AML, T-PLL)
- Dynamics of molecular regulation networks
- Theoretical concepts of stem cell organisation (theoretical setm cell biology)
- Clonal competition phenomena and stem cell/niche interactions
Biostatistics/Bioinformatics:
- Statistical modelling (e.g. mixed-effect models)
- Analysis of cellular genealogies
- Analysis of single cell tracking data
- Model-based trial design
- Integrative analysis of molecular data (e.g. NGS-based)
Medical Informatics:
- Data integration models
- „Big Data“ in oncology
- Integration of model predictions in processes of clinical decision-making
Publications
2024
-
Hybrid Immunity Protects against Antibody Fading after SARS-CoV-2mRNA Vaccination in Kidney Transplant Recipients, Dialysis Patients, and Medical Personnel: 9 Months Data from the Prospective, Observational Dia-Vacc Study, 19 Jul 2024, In: Vaccines : open access journal. 12, 7, 20 p., 801Electronic (full-text) versionResearch output: Contribution to journal > Research article
-
Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche, 21 Mar 2024, In: Leukemia. 38, 5, p. 936-946, 11 p.Electronic (full-text) versionResearch output: Contribution to journal > Review article
-
9-Month observational Dia-Vacc study of vaccine type influence on SARS-CoV-2 immunity in dialysis and kidney transplant patients, 12 Jan 2024, In: Vaccine. 42, 2, p. 120-128, 9 p.Electronic (full-text) versionResearch output: Contribution to journal > Research article
-
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold, 10 Jan 2024, In: Molecular cancer. 23, 1, 8 p., 10Electronic (full-text) versionResearch output: Contribution to journal > Letter
2023
-
Clinicum Digitale: Interim Report of an Interprofessional Course to Shape Digital Health Pioneers: Interim Report of an Interprofessional Course to Shape Digital Health Pioneers, 31 Oct 2023, 2023 IEEE 2nd German Education Conference, GECon 2023. p. 1-6Electronic (full-text) versionResearch output: Contribution to book/conference proceedings/anthology/report > Conference contribution
-
Data integration between clinical research and patient care: A framework for context-depending data sharing and in silico predictions, 15 May 2023, In: PLOS digital health. 2, 5, 17 p., e0000140Electronic (full-text) versionResearch output: Contribution to journal > Research article
2022
-
Modelling of immune response in chronic myeloid leukemia patients suggests potential for treatment reduction prior to cessation, 6 Dec 2022, In: Frontiers in oncology. 12, 1028871Electronic (full-text) versionResearch output: Contribution to journal > Research article
-
Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia, Sep 2022, In: PloS one. 17, 9, e0274463Electronic (full-text) versionResearch output: Contribution to journal > Research article
-
Functional improvement in children and adolescents with primary headache after an interdisciplinary multimodal therapy program: the DreKiP study, 25 Aug 2022, In: The Journal of headache and pain. 23, 1, 109Electronic (full-text) versionResearch output: Contribution to journal > Research article
-
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy, Jul 2022, In: Leukemia. 36, 7, p. 1879-1886, 8 p.Electronic (full-text) versionResearch output: Contribution to journal > Research article